Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer
Genes & Development · 2024
DOI: 10.1101/gad.351455.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, 2024. Verfasst von Hexiao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. Hauptthemen laut MEDLINE: Interferons, Breast Neoplasms, MRE11 Homologue Protein, Organoids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The MRE11 complex (comprising MRE11, RAD50, and NBS1) is integral to the maintenance of genome stability. We previously showed that a hypomorphic Mre11 mutant mouse strain ( Mre11 ATLD1/ATLD1 ) was highly susceptible to oncogene-induced breast cancer. Here we used a mammary organoid system to examine which MRE11-dependent responses are tumor-suppressive. We found that Mre11 ATLD1/ATLD1 organoids exhibited an elevated interferon-stimulated gene (ISG) signature and sustained changes in chromatin accessibility. This Mre11 ATLD1/ATLD1 phenotype depended on DNA binding of a nuclear innate immune sensor, IFI205. Ablation of Ifi205 in Mre11 ATLD1/ATLD1 organoids restored baseline and oncogene-induced chromatin accessibility patterns to those observed in WT. Implantation of Mre11 ATLD1/ATLD1 organoids and activation of the oncogene led to aggressive metastatic breast cancer. This outcome was reversed in implanted Ifi205 −/− Mre11 ATLD1/ATLD1 organoids. These data reveal a connection between innate immune signaling and tumor development in the mammary epithelium. Given the abundance of aberrant DNA structures that arise in the context of genome instability syndromes, the data further suggest that cancer predisposition in those contexts may be partially attributable to chronic innate immune transcriptional programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
- Biochemistry, Structural Biology, Cell Biology, Developmental Biology, and Molecular Biology (BCMB) Program, Weill Cornell Graduate School of Medical Sciences, New York, New York 10065, USA.
- Computational and Systems Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
- Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
- Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA; petrinij@mskcc.org.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- Memorial Sloan Kettering Cancer Center Core Grant
- Memorial Sloan Kettering Center for Experimental Immuno-Oncology Scholars Program
Zitieren
APA
Wang, H., Canasto-Chibuque, C., Kim, J. H., Hohl, M., Leslie, C., Reis-Filho, J. S., & Petrini, J. H. J. (2024). Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer. Genes & Development. https://doi.org/10.1101/gad.351455.123
Vancouver
Wang H, Canasto-Chibuque C, Kim JH, Hohl M, Leslie C, Reis-Filho JS, et al. Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer. Genes & Development. 2024. doi:10.1101/gad.351455.123
BibTeX
@article{Wang2024,
author = {Wang, Hexiao and Canasto-Chibuque, Claudia and Kim, Jun Hyun and Hohl, Marcel and Leslie, Christina and Reis-Filho, Jorge S and Petrini, John H J},
title = {Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer},
journal = {Genes & Development},
year = {2024},
doi = {10.1101/gad.351455.123}
}
EUVIMED